Metraipolis › archive › dc_fdef57799fe2

L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson's disease: real-life mobility insights from wearable sensors — Europe PMC PMID:42376452

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42376452
DOI: 10.3389/fneur.2026.1812950
License (as archived): solo-consultazione
Archived: 2026-10-31T11:19:13.884Z
SHA-256 of the archived text: 069a6a585343f52b90b391101c945e163771721ea35c5f24a4d39c8666843ba2
Stable URL of this page: https://metraipolis.com/documento/dc_fdef57799fe2

How to cite

L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson's disease: real-life mobility insights from wearable sensors — Europe PMC PMID:42376452 — Europe PMC (en), https://europepmc.org/article/MED/42376452 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdef57799fe2 (Metraipolis archive dc_fdef57799fe2, sha256 069a6a585343f52b90b391101c945e163771721ea35c5f24a4d39c8666843ba2)

BibTeX

@misc{dcfdef57799fe2,
  title = {L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson's disease: real-life mobility insights from wearable sensors — Europe PMC PMID:42376452},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42376452},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdef57799fe2; sha256 069a6a585343f52b90b391101c945e163771721ea35c5f24a4d39c8666843ba2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376452. Agents can read the archived copy with the MCP tool read_document.